Medicine News and Research

RSS

Viewpoints: Gephardt and Leavitt's bipartisan push for biomedical innovation; suggestions for the super committee

We Americans are rightfully proud of our can-do spirit. We know that our nation is capable of uniting for a common goal - and triumphing. In this time of economic challenge and political divisiveness, we are proposing an idea for our country's next common mission: biomedical innovation. From our combined decades of experience leading in the Congress and the U.S. Department of Health and Human Services, we see the biomedical frontier as America's greatest opportunity to align our nation's competencies and resources for a better future.

28 Oct 2011

La Jolla Institute becomes 5th participant in novel stem cell research collaboration

The La Jolla Institute for Allergy & Immunology has become the fifth organization in the prestigious Sanford Consortium for Regenerative Medicine, joining colleagues from the Salk Institute for Biological Studies, The Scripps Research Institute, University of California, San Diego and the Sanford-Burnham Medical Research Institute in the first-of-its-kind multi-institutional stem cell research collaboration.

28 Oct 2011

Roundup: Mass. offers plan to cut costs for dual eligibles; Oregon's high hopes for coordinated care organizations

The governor of Massachusetts wants to hire private insurers or other third parties to manage care for the poor and chronically ill patients who use a disproportionate share of public health-care dollars. The proposal comes as state and federal officials search for a cheaper way to deliver health care to people known as "dual eligibles." These are the 9.2 million in the U.S. who receive both Medicare, the federal program for those 65 and older or disabled, and Medicaid, the joint state-federal health plan for the poor.

28 Oct 2011

Novel scarless surgery effectively removes skull base tumors

A technique developed by Johns Hopkins surgeons is providing a new route to get to and remove tumors buried at the base of the skull: through the natural hole behind the molars, above the jawbone and beneath the cheekbone.

27 Oct 2011

HDM and SCT increase overall survival for patients with AL amyloidosis

A team of researchers led by Boston University School of Medicine (BUSM), has found treatment of selected immunoglobulin light chain (AL) amyloidosis patients with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) resulted in a high organ response rate and increased overall survival (OS), even for those patients who did not achieve a hematologic complete response.

27 Oct 2011

Researchers uncover molecular pathway critical to cardiac arrhythmia

University of Maryland School of Medicine researchers have uncovered a previously unknown molecular pathway that is critical to understanding cardiac arrhythmia and other heart muscle problems.

27 Oct 2011

New MRSA strains are not directly descended from old ones: Study

Check into a hospital and you run the risk of infection with a methicillin-resistant strain of the bacterium Staphylococcus aureus, or MRSA. But present day MRSA might have been worse if it had descended directly from a 1950s version of the bug, according to a study co-authored by Barry N. Kreiswirth, PhD, a professor at the Public Health Research Institute of UMDNJ-New Jersey Medical School, and published in the Proceedings of the National Academy of Sciences.

27 Oct 2011

U of A researchers discover potential new drug target for MS

Medical researchers at the University of Alberta have discovered a potential new drug target for Multiple Sclerosis that could prevent physical disability associated with the disease, once a new drug is developed.

27 Oct 2011

Medtronic initiates Symplicity System clinical study in treatment-resistant hypertension

Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.

From Medtronic 27 Oct 2011

Nanoparticles could help increase retention of osteoarthritis drugs in knee cavity

A novel study demonstrates that using nanoparticles to deliver osteoarthritis drugs to the knee joint could help increase the retention of the drug in the knee cavity, and therefore reduce the frequency of injections patients must receive.

27 Oct 2011

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. coli asparaginase, a key chemotherapy drug for this type of leukemia.

27 Oct 2011

Scripps researcher receives U-M's Eric J. Topol Professorship in Cardiovascular Medicine

The University of Michigan Medical School today announced the establishment of the Eric J. Topol Professorship in Cardiovascular Medicine. A world-renowned cardiologist, Dr. Topol is currently chief academic officer at Scripps Health and a senior cardiologist practitioner at Scripps Clinic.

27 Oct 2011

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Bristol-Myers Squibb Company and Gilead Sciences, Inc. today announced a licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination containing Bristol-Myers Squibb's protease inhibitor REYATAZ (atazanavir sulfate) and Gilead's cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain HIV medicines to potentially allow for one pill once daily dosing.

27 Oct 2011

International diabetes researchers to engineer artificial pancreas system

The National Institutes for Health (NIH) have awarded $4.5 million to a group of international diabetes researchers to engineer an artificial pancreas system that will monitor and adapt to the body's complex real-time changes in behavior and physiology.

27 Oct 2011

Late pregnancy snoring could harm mother and baby alike

Nearly half of pregnant women may develop snoring by their final trimester and this could lead to dangerous health problems for mother and baby, Australian sleep researchers have shown. According to professor of medicine, Colin Sullivan, research found woman who started snoring during the later stages of pregnancy were at increased risk of developing high blood pressure.

27 Oct 2011

Blood biomarker panel can predict survival in IPF patients

A panel of blood proteins can predict which patients with the progressive lung disease idiopathic pulmonary fibrosis (IPF) are likely to live at least five years or to die within two years, say researchers at the University of Pittsburgh School of Medicine and Centocor R&D.

27 Oct 2011

Insulin resistance paradox

Obesity and insulin resistance are almost inevitably associated with increases in lipid accumulation in the liver, a serious disease that can deteriorate to hepatitis and liver failure. A real paradox in understanding insulin resistance is figuring out why insulin-resistant livers make more fat. Insulin resistance occurs when the body does a poor job of lowering blood sugars.

27 Oct 2011

Super broccoli on the shelves to protect from heart disease

British scientists unveiled a new breed of broccoli that experts say packs heavy on nutritional values. The new broccoli was specially grown to contain two to three times the normal amount of glucoraphanin, a nutrient believed to help ward off heart disease. Glucoraphanin breaks fat down in the body, preventing it from clogging the arteries.

27 Oct 2011

WSU researcher to learn more about links between stress and drug use

A Wayne State University researcher is using a three-year, $1.55 million grant from the National Institute on Drug Abuse of the National Institutes of Health to learn more about the links between stress and drug use by applying behavioral economics.

27 Oct 2011

Chest X ray for lung cancer fails to improve survival compared to no screening: Study

This study followed 154,901 participants, about half of whom were women. About 10 percent were current smokers, and the rest were nearly evenly divided between former smokers and people who never smoked. Subjects were either offered a chest X-ray or no screening at all.

27 Oct 2011

Medicine News and Research

Viewpoints: Gephardt and Leavitt's bipartisan push for biomedical innovation; suggestions for the super committee

La Jolla Institute becomes 5th participant in novel stem cell research collaboration

Roundup: Mass. offers plan to cut costs for dual eligibles; Oregon's high hopes for coordinated care organizations

Novel scarless surgery effectively removes skull base tumors

HDM and SCT increase overall survival for patients with AL amyloidosis

Researchers uncover molecular pathway critical to cardiac arrhythmia

New MRSA strains are not directly descended from old ones: Study

U of A researchers discover potential new drug target for MS

Medtronic initiates Symplicity System clinical study in treatment-resistant hypertension

Nanoparticles could help increase retention of osteoarthritis drugs in knee cavity

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

Scripps researcher receives U-M's Eric J. Topol Professorship in Cardiovascular Medicine

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

International diabetes researchers to engineer artificial pancreas system

Late pregnancy snoring could harm mother and baby alike

Blood biomarker panel can predict survival in IPF patients

Insulin resistance paradox

Super broccoli on the shelves to protect from heart disease

WSU researcher to learn more about links between stress and drug use

Chest X ray for lung cancer fails to improve survival compared to no screening: Study

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News